OnabotulinumtoxinA effects on trigeminal nociceptors

BACKGROUND: OnabotulinumtoxinA (onabotA) is approved globally for prevention of chronic migraine; however, the classical mechanism of action of onabotA in motor and autonomic neurons cannot fully explain the effectiveness of onabotulinumtoxinA in this sensory neurological disease. We sought to explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Ashley A, Nelson, Mariana, Wickware, Christopher, Choi, Shinbe, Moon, Gene, Xiong, Emma, Orta, Lily, Brideau-Andersen, Amy, Brin, Mitchell F, Broide, Ron S, Liedtke, Wolfgang, Moore, Carlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652784/
https://www.ncbi.nlm.nih.gov/pubmed/36751871
http://dx.doi.org/10.1177/03331024221141683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652784/
https://www.ncbi.nlm.nih.gov/pubmed/36751871
http://dx.doi.org/10.1177/03331024221141683

Ejemplares similares